Glucagon-like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
Bi Z, Jiao Z, Li J, Fang Z
Summary
This comprehensive meta-analysis examined the relationship between GLP-1 receptor agonist use and depression risk. The review synthesizes evidence from multiple randomized controlled trials and real-world studies to clarify whether GLP-1 RAs increase, decrease, or have no effect on depressive symptoms in patients with type 2 diabetes and obesity.
Clinical Significance
The debate over GLP-1 RA psychiatric safety has been ongoing since early pharmacovigilance signals emerged. This meta-analysis provides the most current synthesis of evidence, critical for clinicians prescribing these medications to patients with comorbid mental health concerns.
Key Findings
- Comprehensive meta-analysis of GLP-1 RA psychiatric safety data
- Addresses the controversial signal around GLP-1 RAs and mental health outcomes
- Synthesizes RCT and real-world evidence across semaglutide, liraglutide, and tirzepatide
- Published in a high-impact psychiatry journal, indicating clinical relevance to mental health prescribing
Clinical Implications
Clinicians prescribing GLP-1 RAs should be aware of this updated evidence on psychiatric safety. The findings help inform shared decision-making for patients with pre-existing depression or anxiety who are candidates for GLP-1 RA therapy.
Verwandte Forschung
Exposure-Adjusted Safety and Efficacy of GLP-1 and GLP-1/GIP Receptor Agonists for Weight Management and Type 2 Diabetes
This comprehensive analysis of FDA regulatory data across 14 medications and over 34,000 safety subj…
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis
This comprehensive meta-analysis evaluated the association between GLP-1 receptor agonist use and de…
GLP-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control
This review synthesizes preclinical and clinical evidence showing that GLP-1 RAs may reduce platelet…
GLP-1 Drugs, Gastrointestinal Function and Critical Illness
This review addresses the peri-operative and ICU management of patients on long-acting GLP-1 therapy…